Literature DB >> 20963763

Hershberger assay to investigate the effects of endocrine-disrupting compounds with androgenic or antiandrogenic activity in castrate-immature male rats.

L Earl Gray1, Johnathan Furr, Joseph S Ostby.   

Abstract

The protocol described in this unit is designed to evaluate the effects of androgenic and antiandrogenic endocrine-disrupting compounds (EDCs) in the castrate-immature male rat. Continuous 10-day exposure of the prepubertal male to chemicals is used to identify androgenic or antiandrogenic activities based on the weights of several androgen-dependent tissues on the day after treatment is ended. Androgen-dependent organ weights and growth, along with kidney, liver, and adrenal weights are measured at necropsy. The androgen-dependent tissues include the ventral prostate, seminal vesicles (with fluid plus coagulating glands), levator ani plus bulbocavernosus muscles, Cowper's glands, and glans penis. Optional measures, which facilitate interpretation of the data when positive effects are detected, include serum testosterone and luteinizing hormone levels. Androgenic chemicals cause increases in one or all of the androgen-dependent tissue weights after being administered by oral gavage or subcutaneously (s.c.) to castrate-immature male rats. Antiandrogenic chemicals cause reductions in androgen-dependent tissue weights after being coadministered with testosterone propionate (s.c.).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 20963763     DOI: 10.1002/0471140856.tx1609s26

Source DB:  PubMed          Journal:  Curr Protoc Toxicol        ISSN: 1934-9254


  8 in total

Review 1.  Xenotransplantation models to study the effects of toxicants on human fetal tissues.

Authors:  Daniel J Spade; Elizabeth V McDonnell; Nicholas E Heger; Jennifer A Sanders; Camelia M Saffarini; Philip A Gruppuso; Monique E De Paepe; Kim Boekelheide
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2014-12-04

2.  Differential response to abiraterone acetate and di-n-butyl phthalate in an androgen-sensitive human fetal testis xenograft bioassay.

Authors:  Daniel J Spade; Susan J Hall; Camelia M Saffarini; Susan M Huse; Elizabeth V McDonnell; Kim Boekelheide
Journal:  Toxicol Sci       Date:  2013-11-27       Impact factor: 4.849

3.  A Conflicted Tale of Two Novel AR Antagonists In Vitro and In Vivo: Pyrifluquinazon Versus Bisphenol C.

Authors:  Leon Earl Gray; Johnathan R Furr; Justin M Conley; Christy S Lambright; Nicola Evans; Mary C Cardon; Vickie S Wilson; Paul M Foster; Phillip C Hartig
Journal:  Toxicol Sci       Date:  2019-04-01       Impact factor: 4.849

4.  Selective androgen receptor modulator RAD140 is neuroprotective in cultured neurons and kainate-lesioned male rats.

Authors:  Anusha Jayaraman; Amy Christensen; V Alexandra Moser; Rebekah S Vest; Chris P Miller; Gary Hattersley; Christian J Pike
Journal:  Endocrinology       Date:  2014-01-15       Impact factor: 4.736

5.  Quantification of the Uncertainties in Extrapolating From In Vitro Androgen Receptor Antagonism to In Vivo Hershberger Assay Endpoints and Adverse Reproductive Development in Male Rats.

Authors:  Leon E Gray; Johnathan R Furr; Christy S Lambright; Nicola Evans; Phillip C Hartig; Mary C Cardon; Vickie S Wilson; Andrew K Hotchkiss; Justin M Conley
Journal:  Toxicol Sci       Date:  2020-08-01       Impact factor: 4.109

Review 6.  REPRODUCTIVE TOXICOLOGY: Environmental exposures, fetal testis development and function: phthalates and beyond.

Authors:  Hui Li; Daniel J Spade
Journal:  Reproduction       Date:  2021-10-05       Impact factor: 3.923

7.  The impact of exogenic testosterone and nortestosterone-decanoate toxicological evaluation using a rat model.

Authors:  Romeo Teodor Cristina; Flavia Hanganu; Eugenia Dumitrescu; Florin Muselin; Monica Butnariu; Adriana Constantin; Viorica Chiurciu
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

8.  Systems Pharmacology Modeling of Prostate-Specific Antigen in Patients With Prostate Cancer Treated With an Androgen Receptor Antagonist and Down-Regulator.

Authors:  H B Mistry; M-A Fabre; J Young; G Clack; P A Dickinson
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-05-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.